BWD
BWD is a PSMA ligand (IC50 = 35.86) . BWD exhibits excellent in vitro stability and high affinity. BWD can enhance tumor uptake and retention. BWD can inhibit tumor growth in vivo. BWD can be studied in anticancer research[1].
Product Specifications
UNSPSC
12352005
Target
PSMA
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
CC1=CC=C(C=C1)CCCC(N[C@@H](C(NCCCCCN(C(C2C3=C(C4=C2C=CC=C4)C=CC=C3)=O)CCCC[C@@H](C(O)=O)NC(N[C@H](CCC(O)=O)C(O)=O)=O)=O)CCCCNC(CN(CCN(CC5)CC(O)=O)CCN(CCN5CC(O)=O)CC(O)=O)=O)=O
Molecular Formula
C64H90N10O17
Molecular Weight
1271.46
References & Citations
[1]Yang Liu, et al., (2025) . In Vitro and In Vivo Study of Novel PSMA-Targeted Radioligands: Enhancing Tumor Uptake and Therapeutic Efficacy through Zwitterionization and Albumin-Binding Strategies. Mol. Pharmaceutics 2025, 22, 7, 3961–3975.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040096-500 1x 500 µL
Histone H1 (AE-4), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940204-100 1x 100 µL
Complement C4d (C4D204), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472960-500 1x 500 µL
Desmin (Muscle Cell Marker) (DES/2960R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400803-500 1x 500 µL
Cytokeratin 8 (KRT8/803), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details